SEC Comment Letter for ALTERITY THERAPEUTICS LTD (ATHE, PRNAF) (CIK 0001131343) (ATHE) — Jul 19, 2005
ALTERITY THERAPEUTICS LTD (ATHE, PRNAF) (CIK 0001131343)
Date: July 19, 2005 · CIK: 0001131343 · Accession: 0000000000-05-036879
AI Filing Summary & Sentiment
Letter
Via Facsimile and U.S. Mail Mail Stop 03-09 June 2, 2005 Mr. Jonas V. Alsenas Chief Executive Officer Prana Biotechnology Limited Level 2, 369 Royal Parade Parkville, Victoria 3052 Australia
Re: Prana Biotechnology Limited Form 20-F for the fiscal year ended June 30, 2004 File No. 0-49843
Dear Mr. Alsenas:
We have completed our review of your Form 20-F and have no further comments at this time.
Sincerely,
Joel Parker
Accounting Branch Chief
??
Show Raw Text
<DOCUMENT> <TYPE>LETTER <SEQUENCE>1 <FILENAME>filename1.txt <TEXT> Via Facsimile and U.S. Mail Mail Stop 03-09 June 2, 2005 Mr. Jonas V. Alsenas Chief Executive Officer Prana Biotechnology Limited Level 2, 369 Royal Parade Parkville, Victoria 3052 Australia Re: Prana Biotechnology Limited Form 20-F for the fiscal year ended June 30, 2004 File No. 0-49843 Dear Mr. Alsenas: We have completed our review of your Form 20-F and have no further comments at this time. Sincerely, Joel Parker Accounting Branch Chief ?? ?? ?? ?? Mr. Alsenas Prana Biotechnology Limited Page 1 </TEXT> </DOCUMENT>